General Information of the Compound
| Compound ID |
CP0076249
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
TOFOGLIFLOZIN
Show/Hide
|
||||||||||||||||||
| Synonyms |
554245W62T
903565-83-3
AKOS027250822
BDBM50396779
CHEBI:136041
CHEMBL2110731
CSG 452
CSG-452
CSG452;CSG-452
DB11824
DTXSID90238097
EC 619-989-0
GTPL9395
KB-76204
MolPort-044-723-920
NCGC00485920-01
R-7201
SB11170
SCHEMBL903156
TOFOGLIFLOZIN
Tofogliflozin
Tofogliflozin [INN]
Tofogliflozin anhydrous
Tofogliflozin anyhydrous
Tube107
UNII-554245W62T
ZINC35826342
apleway
compound 16d [PMID: 22889351]
deberza
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C22H26O6
|
||||||||||||||||||
| Molecular Weight |
386.444
|
||||||||||||||||||
| Canonical SMILES |
CCc1ccc(Cc2ccc3CO[C@]4(O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)c3c2)cc1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C22H26O6/c1-2-13-3-5-14(6-4-13)9-15-7-8-16-12-27-22(17(16)10-15)21(26)20(25)19(24)18(11-23)28-22/h3-8,10,18-21,23-26H,2,9,11-12H2,1H3/t18-,19-,20+,21-,22+/m1/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
VWVKUNOPTJGDOB-BDHVOXNPSA-N
|
||||||||||||||||||
| CAS |
903565-83-3
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
| DrugBank ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound